
Sonoma Pharmaceuticals, Inc. – NASDAQ:SNOA
Sonoma Pharmaceuticals stock price today
Sonoma Pharmaceuticals stock price monthly change
Sonoma Pharmaceuticals stock price quarterly change
Sonoma Pharmaceuticals stock price yearly change
Sonoma Pharmaceuticals key metrics
Market Cap | 3.43M |
Enterprise value | 834.72K |
P/E | -0.42 |
EV/Sales | 0.06 |
EV/EBITDA | -0.12 |
Price/Sales | 0.23 |
Price/Book | 0.53 |
PEG ratio | -0.16 |
EPS | -1.76 |
Revenue | 11.65M |
EBITDA | -7.13M |
Income | -6.26M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -54.05% |
Oper. margin | -51.61% |
Gross margin | 29.54% |
EBIT margin | -51.61% |
EBITDA margin | -61.24% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSonoma Pharmaceuticals stock price history
Sonoma Pharmaceuticals stock forecast
Sonoma Pharmaceuticals financial statements
Dec 2021 | 2.90M | -944K | -32.53% |
---|---|---|---|
Mar 2022 | 2.29M | -2.94M | -128.11% |
Mar 2023 | 3.01M | -1.30M | -43.4% |
Mar 2024 | 3.43M | -1.06M | -31.03% |
Sep 2025 | 5.24M | -545.45K | -10.41% |
---|---|---|---|
Oct 2025 | 5.01M | -312.14K | -6.23% |
Dec 2025 | 5.42M | -156.07K | -2.88% |
Mar 2026 | 6M | -109.09K | -1.82% |
Analysts Price target
Financials & Ratios estimates
Sep 2022 | 14962000 | 7.94M | 53.07% |
---|---|---|---|
Dec 2022 | 13928000 | 8.36M | 60.09% |
Mar 2023 | 16231000 | 8.25M | 50.85% |
Mar 2024 | 14893000 | 8.75M | 58.79% |
Dec 2021 | -326K | -49K | 463K |
---|---|---|---|
Mar 2022 | -1.39M | -61K | 222K |
Mar 2023 | -2.44M | -82K | 3.37M |
Mar 2024 | 152K | 18K | 622K |
Sonoma Pharmaceuticals alternative data
Aug 2023 | 9 |
---|---|
Sep 2023 | 9 |
Oct 2023 | 9 |
Nov 2023 | 9 |
Dec 2023 | 9 |
Jan 2024 | 9 |
Feb 2024 | 9 |
Mar 2024 | 9 |
Apr 2024 | 9 |
May 2024 | 9 |
Jun 2024 | 9 |
Jul 2024 | 10 |
Sonoma Pharmaceuticals other data
Period | Buy | Sel |
---|---|---|
Aug 2017 | 3793 | 0 |
Nov 2017 | 4789 | 0 |
Mar 2018 | 7273 | 0 |
Quarter | Transcript |
---|---|
Q2 2019 9 Nov 2018 | Q2 2019 Earnings Call Transcript |
Q1 2019 9 Aug 2018 | Q1 2019 Earnings Call Transcript |
Q4 2018 14 Jun 2018 | Q4 2018 Earnings Call Transcript |
Q3 2018 8 Feb 2018 | Q3 2018 Earnings Call Transcript |
-
What's the price of Sonoma Pharmaceuticals stock today?
One share of Sonoma Pharmaceuticals stock can currently be purchased for approximately $5.22.
-
When is Sonoma Pharmaceuticals's next earnings date?
Unfortunately, Sonoma Pharmaceuticals's (SNOA) next earnings date is currently unknown.
-
Does Sonoma Pharmaceuticals pay dividends?
No, Sonoma Pharmaceuticals does not pay dividends.
-
How much money does Sonoma Pharmaceuticals make?
Sonoma Pharmaceuticals has a market capitalization of 3.43M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 4.05% to 12.74M US dollars.
-
What is Sonoma Pharmaceuticals's stock symbol?
Sonoma Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "SNOA".
-
What is Sonoma Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Sonoma Pharmaceuticals?
Shares of Sonoma Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Sonoma Pharmaceuticals's key executives?
Sonoma Pharmaceuticals's management team includes the following people:
- Ms. Amy M. Trombly Chief Executive Officer & Pres(age: 57, pay: $428,000)
- Mr. Bruce Thornton Chief Operating Officer & Corporation Sec.(age: 61, pay: $365,000)
- Mr. Jerome Dvonch Chief Financial Officer(age: 56, pay: $221,910)
-
How many employees does Sonoma Pharmaceuticals have?
As Jul 2024, Sonoma Pharmaceuticals employs 10 workers, which is 11% more then previous month and 11% more then previous quarter.
-
When Sonoma Pharmaceuticals went public?
Sonoma Pharmaceuticals, Inc. is publicly traded company for more then 18 years since IPO on 25 Jan 2007.
-
What is Sonoma Pharmaceuticals's official website?
The official website for Sonoma Pharmaceuticals is sonomapharma.com.
-
Where are Sonoma Pharmaceuticals's headquarters?
Sonoma Pharmaceuticals is headquartered at 645 Molly Lane, Woodstock, GA.
-
How can i contact Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals's mailing address is 645 Molly Lane, Woodstock, GA and company can be reached via phone at +800 7599305.
Sonoma Pharmaceuticals company profile:

Sonoma Pharmaceuticals, Inc.
sonomapharma.comNASDAQ
10
Drug Manufacturers - Specialty & Generic
Healthcare
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens, as well as antibiotic-resistant strains that slow the natural healing of wounds. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Ocucyn eyelid and eyelash cleanser; Gramaderm for the treatment of topical mild to moderate acne; Nanocyn, a hospital-grade disinfectant; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia.
Woodstock, GA 30189
CIK: 0001367083
ISIN: US83558L2043
CUSIP: 83558L204